Ensysce Biosciences Inc
ENSC3.670USD
+1.800+96.26%
收盘 04/23, 16:00（美东）报价延迟15分钟
4.98M总市值
亏损市盈率 TTM
关于 Ensysce Biosciences Inc 公司
Ensysce Biosciences, Inc. 是一家临床阶段制药公司。该公司开发用于缓解严重疼痛的解决方案，同时降低阿片类药物误用、滥用和过量服用的可能性。其产品线包括两个新药平台：一种抗滥用阿片类药物前药技术，即胰蛋白酶激活滥用保护 (TAAP) 平台，以及一种过量服用保护阿片类药物前药技术，即多药片滥用保护 (MPAR) 平台。TAAP 平台旨在改善对慢性疼痛患者的护理，同时降低与处方阿片类药物滥用相关的人力和经济成本。MPAR 平台与其 TAAP 前药结合使用，旨在防止处方药滥用，同时也减少过量服用的发生。此外，作为其过量服用保护组合产品的一种成分，萘莫司他二甲磺酸盐 (nafamostat) 也正在开发中，用于治疗感染和肺部疾病。
公司简介
公司代码ENSC
公司名称Ensysce Biosciences Inc
上市日期Dec 01, 2017
成立日期2017
CEODr. Lynn D. Kirkpatrick, Ph.D.
员工数量7
证券类型Ordinary Share
年结日Dec 01
公司地址7946 Ivanhoe Avenue, Suite 201
城市LA JOLLA
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编92037
电话18582634196
网址https://ensysce.com/
公司代码ENSC
上市日期Dec 01, 2017
成立日期2017
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. David Carl Humphrey, CPA
Mr. David Carl Humphrey, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
10.00
--
Dr. Linda Pestano, Ph.D.
Dr. Linda Pestano, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
Mr. William H.C. Chang
Mr. William H.C. Chang
Independent Director
Independent Director
--
--
Ms. Lee M. Rauch
Ms. Lee M. Rauch
Independent Director
Independent Director
--
--
Mr. Geoffrey Birkett
Mr. Geoffrey Birkett
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Lynn D. Kirkpatrick, Ph.D.
Dr. Lynn D. Kirkpatrick, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Steve R. Martin
Mr. Steve R. Martin
Independent Director
Independent Director
--
--
Bob G. Gower ,
Bob G. Gower ,
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Jeffrey Millard, Ph.D.
Dr. Jeffrey Millard, Ph.D.
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Curtis Rosebraugh, M.D.
Dr. Curtis Rosebraugh, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. David Carl Humphrey, CPA
Mr. David Carl Humphrey, CPA
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
10.00
--
Dr. Linda Pestano, Ph.D.
Dr. Linda Pestano, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
Mr. William H.C. Chang
Mr. William H.C. Chang
Independent Director
Independent Director
--
--
Ms. Lee M. Rauch
Ms. Lee M. Rauch
Independent Director
Independent Director
--
--
Mr. Geoffrey Birkett
Mr. Geoffrey Birkett
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Lynn D. Kirkpatrick, Ph.D.
Dr. Lynn D. Kirkpatrick, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 3月2日 周日
更新时间: 3月2日 周日
持股股东
股东类型
持股股东
股东统计
占比
Perceptive Advisors LLC
5.27%
Adage Capital Management, L.P.
3.04%
Gower (Robert G)
0.49%
FNY Investment Advisers LLC
0.18%
Benton (Andrew K. J.D.)
0.08%
Other
90.93%
持股股东
股东统计
占比
Perceptive Advisors LLC
5.27%
Adage Capital Management, L.P.
3.04%
Gower (Robert G)
0.49%
FNY Investment Advisers LLC
0.18%
Benton (Andrew K. J.D.)
0.08%
Other
90.93%
股东类型
股东统计
占比
Private Equity
5.27%
Hedge Fund
3.07%
Individual Investor
0.63%
Investment Advisor/Hedge Fund
0.18%
Investment Advisor
0.04%
Other
90.81%
机构持股
更新时间: 2月24日 周一
更新时间: 2月24日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q1
35
151.14K
9.19%
-181.20K
2024Q4
41
152.48K
11.69%
-180.25K
2024Q3
42
173.09K
26.96%
+116.42K
2024Q2
41
44.94K
12.13%
-919.00
2024Q1
43
31.95K
18.34%
-413.00
2023Q4
44
15.51K
10.50%
-18.28K
2023Q3
49
27.39K
26.75%
-10.01K
2023Q2
49
42.64K
49.41%
+30.89K
2023Q1
50
17.95K
33.35%
+9.03K
2022Q4
49
6.68K
34.88%
+1.19K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Perceptive Advisors LLC
86.67K
5.27%
--
--
Mar 31, 2025
Adage Capital Management, L.P.
50.00K
3.04%
+50.00K
--
Dec 31, 2024
Gower (Robert G)
8.13K
0.49%
--
--
Mar 07, 2025
FNY Investment Advisers LLC
3.00K
0.18%
+3.00K
--
Dec 31, 2024
Benton (Andrew K. J.D.)
1.33K
0.08%
--
--
Mar 07, 2025
Chang (William H C)
722.00
0.04%
-1.33K
-64.85%
Mar 07, 2025
UBS Financial Services, Inc.
595.00
0.04%
-6.92K
-92.08%
Dec 31, 2024
Tower Research Capital LLC
438.00
0.03%
+8.00
+1.86%
Dec 31, 2024
Kirkpatrick (D. Lynn)
107.00
0.01%
+1.00
+0.94%
Mar 07, 2025
BlackRock Institutional Trust Company, N.A.
64.00
0%
-1.00
-1.54%
Dec 31, 2024
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
公告日期
类型
比率
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Dec 03, 2024
Merger
15<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
Mar 30, 2023
Merger
12<1
Oct 27, 2022
Merger
20<1
Oct 27, 2022
Merger
20<1
查看更多